Skip to content

Liposomal Bupivacaine versus Ropivacaine with Dexamethasone on Rebound Pain following Ankle Surgery: A Clinical Study

Liposomal Bupivacaine versus Ropivacaine with Dexamethasone on Rebound Pain following Ankle Surgery: A Clinical Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124794
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who are scheduled to undergo open reduction and internal fixation for ankle fractures

Interventions

Control group:The control group received a nerve block injection of 0.375% ropivacaine and 5mg dexamethasone, totaling 30ml.
Trial group:The experimental group injected 133mg of bupivacaine lipid emulsion in 20ml of physiological saline, totaling 30ml.

Sponsors

Wuxi 9th Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.If the surgical indications are met, ankle surgery will be performed at an elective date. 2. Age 18 to 60 years old; 3. Classified as grade I to II by the American Society of Anesthesiologists (ASA); 4. Be able to correctly understand and answer questions, and accurately express the feeling of pain.

Exclusion criteria

Exclusion criteria: 1. Related allergies; 2. Current gastrointestinal bleeding; 3. Other injuries requiring opioid analgesics; 4. Habitual daily use of opioids; 5. Cognitive or mental function disorders or substance abuse; 6. Logistical reasons; 7. Lower limb neurological dysfunction; 8. Pregnancy or breastfeeding; 9. Injection site infection; 10. Acute porphyria; 11. Kidney disease requiring dialysis.

Design outcomes

Primary

MeasureTime frame
Incidence of rebound pain;Rebound pain occurs when and lasts;

Secondary

MeasureTime frame
NRS pain score;Opioid consumption;Postoperative nausea and vomiting;Sleep quality score;Quality of recovery scores;

Countries

China

Contacts

Public ContactWang Meng

Wuxi 9th Affiliated Hospital of Soochow University

wxfy2071@163.com+86 510 8581 1650

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026